News
24.10.12
Alliance between Fondazione Telethon and biopharmaceutical company Shire for research and development of new therapies for rare genetic diseases
Fondazione Telethon has signed an important agreement to collaborate with the international pharma company Shire plc.
18.10.10
A Tripartite Alliance to Cure Seven Genetic Diseases
Fondazione Telethon, Ospedale San Raffaele, and GlaxoSmithKline have entered into a strategic alliance to develop and make available innovative gene therapies for seven severe rare genetic diseases.
